Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Verrica Pharmaceuticals (VRCA) Q2 2024 Earnings
VRCA
13
May
Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.56
-0.44
-0.33
-0.21
Details
Expected EPS
-0.44695
Actual EPS
-0.44
Surprise EPS
0.01
Surprise Percent
+1.55%
Description
Verrica Pharmaceuticals (VRCA) has reported earnings of -0.44 per share for Q2 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login